Jiangsu Hengrui Medicine
600276.SS
#508
Rank
A$60.75 B
Marketcap
$9.52
Share price
-0.27%
Change (1 day)
0.45%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total assets

Total assets on the balance sheet as of June 2024 : A$9.94 B

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total assets are A$9.94 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Jiangsu Hengrui Medicine - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2022-12-31A$9.02 B6.48%
2021-12-31A$8.47 B22.64%
2020-12-31A$6.91 B23.14%
2019-12-31A$5.61 B20.81%
2018-12-31A$4.64 B30.78%
2017-12-31A$3.55 B24.06%
2016-12-31A$2.86 B17.57%
2015-12-31A$2.43 B36.07%
2014-12-31A$1.78 B33.79%
2013-12-31A$1.33 B46.74%
2012-12-31A$0.91 B21.92%
2011-12-31A$0.74 B28.48%
2010-12-31A$0.58 B18.54%
2009-12-31A$0.49 B2.47%
2008-12-31A$0.47 B48.38%
2007-12-31A$0.32 B35.3%
2006-12-31A$0.23 B9.62%
2005-12-31A$0.21 B10.93%
2004-12-31A$0.19 B-16.88%
2003-12-31A$0.23 B-8.6%
2002-12-31A$0.25 B-2.5%
2001-12-31A$0.26 B